Skip to content
OpenCapital
Get started

Supernus Pharmaceuticals SUPN Current ratio

Current ratio at other companies

AbbVie logo
AbbVieABBV
0.8×0.0×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
7.1×+1.0×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
1.4×-0.6×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
2.9×-0.2×
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2×-1.3×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.6×+0.7×

Other financials

Income statement

See full
Revenue$207.7M+38.6%
Gross profit$184.3M+37.5%
Operating income-$8.3M+18.8%
Net income-$2.3M+80.6%
EPS (diluted)-$0.04+81.0%

Balance sheet

See full
Cash & equivalents$186.3M+60.8%
Total debt$40.9M+26.6%
Total equity$1.1B+4.5%
Total assets$1.5B+11.4%

Cash flow

See full
Operating cash flow$66.5M+117%
CapEx--100%
Free cash flow$66.5M+120%

Valuation

See full
Market cap$2.58B+62.8%
Enterprise value$2.44B+62.3%
P/S3.3×+0.9×

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-7.8%-18.9pp
Net margin-3.7%-13.0pp
FCF margin27.9%+3.4pp

Returns & leverage

See full
Return on equity-2.8%-9.1pp
Debt / equity0×0.0×

Where this comes from

Calculated from Supernus Pharmaceuticals’s reported figures.

total current assets/total current liabilities=2×

Based on the most recent quarter.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Supernus Pharmaceuticals's current ratio?
Supernus Pharmaceuticals (SUPN) reported current ratio of 2× in Q1 2026.
How has Supernus Pharmaceuticals's current ratio changed year-over-year?
Supernus Pharmaceuticals's current ratio decreased by 19.8% year-over-year, from 2.4× to 2×.
What is the long-term trend for Supernus Pharmaceuticals's current ratio?
Over 5 years (2020 to 2025), Supernus Pharmaceuticals's current ratio has grown at a -5.8% compound annual growth rate (CAGR), from 2.6× to 1.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.